Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial
Toshiaki Takahashi, Takeharu Yamanaka, Takashi Seto et al. · The Lancet Oncology · 2017
Cited by 549 works. doi:10.1016/s1470-2045(17)30230-9
Authors
- Toshiaki Takahashi
- Takeharu Yamanaka
- Takashi Seto
- Hideyuki Harada
- Hiroshi Nokihara
- Hideo Saka
- Makoto Nishio
- Hiroyasu Kaneda
- Koichi Takayama
- Osamu Ishimoto
- Hiroshige Yoshioka
- Motoko Yoshikawa TACHIHARA
- Hiroshi Sakai
- Kōichi Goto
- Nobuyuki Yamamoto
References
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
- Interim analysis: The alpha spending function approach
- Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission
- Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung Cancer
- Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
- Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete Remission
- Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging.
- Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial
- Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis
- Diagnostic Accuracy of MRI Compared to CCT in Patients with Brain Metastases